{{Rsnum
|rsid=1610677
|Gene=HCG2P7
|Chromosome=6
|position=29821394
|Orientation=minus
|GMAF=0.4977
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 30.8 | 46.2 | 23.1
| HCB | 14.4 | 49.2 | 36.4
| JPT | 6.4 | 43.6 | 50.0
| YRI | 16.3 | 51.1 | 32.6
| ASW | 21.8 | 60.0 | 18.2
| CHB | 14.4 | 49.2 | 36.4
| CHD | 13.2 | 52.8 | 34.0
| GIH | 5.1 | 37.8 | 57.1
| LWK | 33.9 | 50.5 | 15.6
| MEX | 0.0 | 0.0 | 0.0
| MKK | 18.8 | 48.7 | 32.5
| TSI | 24.8 | 50.5 | 24.8
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21653640
|Trait=None
|Title=Pathway-driven gene stability selection of two rheumatoid arthritis GWAS identifies and validates new susceptibility genes in receptor mediated signalling pathways.
|RiskAllele=
|Pval=4E-15
|OR=1.3200
|ORtxt=[1.79-1.41]
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}